A diagnosis of ductal carcinoma in situ (DCIS) might seem reassuring compared to invasive breast cancer, but recent research paints a more nuanced picture about this condition that affects roughly ...
The incidence of invasive breast cancer after conservative treatment for ductal carcinoma in situ (DCIS) decreased by more than 50% over the past 30 years, data from a Dutch cancer registry showed.
DCIS is a pre-invasive breast cancer condition with uncertain progression, often leading to aggressive treatment despite its "stage 0" classification. The lack of definitive guidance for DCIS ...
NEW ORLEANS -- A search for biomarkers to predict recurrence of ductal carcinoma in situ (DCIS) instead showed that a substantial fraction of recurrences had genetically distinct features from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results